183 related articles for article (PubMed ID: 16532394)
1. Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.
Bishop DF; Johansson A; Phelps R; Shady AA; Ramirez MC; Yasuda M; Caro A; Desnick RJ
Am J Hum Genet; 2006 Apr; 78(4):645-58. PubMed ID: 16532394
[TBL] [Abstract][Full Text] [Related]
2. Congenital erythropoietic porphyria: characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes.
Bishop DF; Clavero S; Mohandas N; Desnick RJ
Mol Med; 2011; 17(7-8):748-56. PubMed ID: 21365124
[TBL] [Abstract][Full Text] [Related]
3. Identification of two new mutations in congenital erythropoietic porphyria.
Bensidhoum M; Ged C; Hombrados I; Moreau-Gaudry F; Hift RS; Meissner P; Sturrock ED; de Verneuil H
Eur J Hum Genet; 1995; 3(2):102-7. PubMed ID: 7552139
[TBL] [Abstract][Full Text] [Related]
4. Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.
Clavero S; Bishop DF; Haskins ME; Giger U; Kauppinen R; Desnick RJ
Hum Mol Genet; 2010 Feb; 19(4):584-96. PubMed ID: 19934113
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of congenital erythropoietic porphyria.
Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
[TBL] [Abstract][Full Text] [Related]
6. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.
To-Figueras J; Badenas C; Mascaró JM; Madrigal I; Merino A; Bastida P; Lecha M; Herrero C
Blood Cells Mol Dis; 2007; 38(3):242-6. PubMed ID: 17270473
[TBL] [Abstract][Full Text] [Related]
7. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
[TBL] [Abstract][Full Text] [Related]
8. Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
Clavero S; Bishop DF; Giger U; Haskins ME; Desnick RJ
Mol Med; 2010; 16(9-10):381-8. PubMed ID: 20485863
[TBL] [Abstract][Full Text] [Related]
9. Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene.
Warner CA; Yoo HW; Roberts AG; Desnick RJ
J Clin Invest; 1992 Feb; 89(2):693-700. PubMed ID: 1737856
[TBL] [Abstract][Full Text] [Related]
10. Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
Di Pierro E; Brancaleoni V; Granata F
Br J Haematol; 2016 May; 173(3):365-79. PubMed ID: 26969896
[TBL] [Abstract][Full Text] [Related]
11. Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene.
Shady AA; Colby BR; Cunha LF; Astrin KH; Bishop DF; Desnick RJ
Br J Haematol; 2002 Jun; 117(4):980-7. PubMed ID: 12060141
[TBL] [Abstract][Full Text] [Related]
12. A knock-in mouse model of congenital erythropoietic porphyria.
Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
[TBL] [Abstract][Full Text] [Related]
13. Congenital erythropoietic porphyria: Recent advances.
Erwin AL; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):288-297. PubMed ID: 30685241
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of congenital erythropoietic porphyria: mutations in the human uroporphyrinogen III synthase gene.
Xu W; Astrin KH; Desnick RJ
Hum Mutat; 1996; 7(3):187-92. PubMed ID: 8829650
[TBL] [Abstract][Full Text] [Related]
15. Congenital erythropoietic porphyria. A mild variant with low uroporphyrin I levels due to a missense mutation (A66V) encoding residual uroporphyrinogen III synthase activity.
Warner CA; Poh-Fitzpatrick MB; Zaider EF; Tsai SF; Desnick RJ
Arch Dermatol; 1992 Sep; 128(9):1243-8. PubMed ID: 1519940
[TBL] [Abstract][Full Text] [Related]
16. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442
[TBL] [Abstract][Full Text] [Related]
18. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
[TBL] [Abstract][Full Text] [Related]
20. C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
Frank J; Wang X; Lam HM; Aita VM; Jugert FK; Goerz G; Merk HF; Poh-Fitzpatrick MB; Christiano AM
Ann Hum Genet; 1998 May; 62(Pt 3):225-30. PubMed ID: 9803266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
